Clarifying the role of FABP-4 in CRC development is important because it may potentially serve as an obesity-associated biomarker that may help identify individuals at high risk of disease who might specifically benefit from primary or secondary prevention strategies. This evidence concerns the gene FABP4 and obesity due to melanocortin 4 receptor deficiency.